|
|
|
Volumn 19, Issue 6 SUPPL. 25, 2001, Pages
|
|
The effect of NSAIDs on the risk of coronary heart disease: Fusion of clinical pharmacology and pharmacoepidemiologic data
|
|
Author keywords
COX 2 inhibitors; Hemostasis; NSAIDs; Prostacyclin; Thromboxane
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ARACHIDONIC ACID;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
DICLOFENAC;
FENBUFEN;
IBUPROFEN;
ICOSANOID;
INDOMETACIN;
KETOPROFEN;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PIROXICAM;
PROSTACYCLIN;
THROMBOXANE A2;
ARTICLE;
CARDIOVASCULAR SYSTEM;
CLINICAL PHARMACOLOGY;
CONTROLLED STUDY;
DRUG EFFECT;
ENZYME INHIBITION;
ENZYME MECHANISM;
EPIDEMIOLOGICAL DATA;
HEART INFARCTION;
HEART PROTECTION;
HEMOSTASIS;
HOMEOSTASIS;
HUMAN;
ISCHEMIC HEART DISEASE;
METHODOLOGY;
PHARMACOEPIDEMIOLOGY;
POPULATION RESEARCH;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK MANAGEMENT;
SMOOTH MUSCLE CONTRACTION;
THROMBOCYTE AGGREGATION;
VASOCONSTRICTION;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CORONARY DISEASE;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
EPOPROSTENOL;
FEMALE;
HUMANS;
ISOENZYMES;
MALE;
MEMBRANE PROTEINS;
MYOCARDIAL INFARCTION;
PHARMACOEPIDEMIOLOGY;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
RISK FACTORS;
THROMBOXANE A2;
|
|
EID: 0034776979
PISSN: 0392856X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (34)
|
|
References (14)
|
